Clinical and genetic features of 5 neonates with centronuclear myopathy caused by MTM1 gene variation.
10.7499/j.issn.1008-8830.2501068
- Author:
Tian XIE
1
;
Jia-Jing GE
1
;
Zi-Ming ZHANG
1
;
Ding-Wen WU
;
Yan-Ping XU
1
;
Li-Ping SHI
1
;
Xiao-Lu MA
1
;
Zheng CHEN
1
Author Information
1. Department of Neonatal Intensive Care Unit, Children's Hospital, Zhejiang University School of Medicine/National Clinical Research Center for Child Health, Hangzhou 310052, China.
- Publication Type:Journal Article
- Keywords:
Centronuclear myopathy;
MTM1 gene;
Neonate
- MeSH:
Humans;
Myopathies, Structural, Congenital/genetics*;
Male;
Infant, Newborn;
Retrospective Studies;
Mutation;
Female;
Protein Tyrosine Phosphatases, Non-Receptor/genetics*
- From:
Chinese Journal of Contemporary Pediatrics
2025;27(9):1071-1075
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To study clinical manifestations and gene mutation features of neonates with centronuclear myopathy.
METHODS:A retrospective analysis was conducted on the medical data of 5 neonates with centronuclear myopathy diagnosed in the Neonatal Intensive Care Unit of Children's Hospital, Zhejiang University School of Medicine from January 2020 to August 2024. The data included gender, gestational age, birth weight, Apgar score, clinical manifestations, creatine kinase level, electromyography, genetic testing results and the outcomes of the infants.
RESULTS:All 5 male neonates had a history of postpartum asphyxia and resuscitation. They all presented with hypotonia, myasthenia, and respiratory failure; two neonates also had swallowing dysfunction. Of the five neonates, three had normal creatine kinase levels, while two had slightly elevated levels. Electromyography was performed for three neonates, among whom two had myogenic damage. MTM1 gene mutations were identified by genetic testing in all five neonates, including two nonsense mutations and three missense mutations, among which one variant had not been previously reported. Four mutations were inherited from the mother, and the other one was a de novo mutation. The five neonates showed no clinical improvement following treatment, failed weaning from mechanical ventilation, and ultimately died after withdrawal of life-sustaining therapy.
CONCLUSIONS:Centronuclear myopathy caused by MTM1 gene mutation often has a severe phenotype and a poor prognosis, and it should be considered for neonates with hypotonia and myasthenia after birth. Genetic testing should be performed as soon as possible.
